The spinal device company saw a 47 percent sales growth year-over-year, which was attributed to Life Spine’s micro-invasive portfolio expansion.
According to Life Spine CFO Omar Faruqi, the company has “remained focused on launching products that are designed with the intention of reducing surgical procedure time, reducing operating costs and providing better patient outcomes.”
More articles on devices:
3 things to know about Viseon Spine
Medacta appoints general manager of U.S. spine division: 3 insights
Medtronic, DePuy Synthes & more: 11 device company launches, releases
